Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults

PHASE1RecruitingINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions

Pre-exposure Prophylaxis Against Pneumonic Plague in Healthy Adults

Interventions

BIOLOGICAL

Monoclonal antibody JST-010

Active study drug

DRUG

Placebo

Trial Locations (1)

RECRUITING

PPD Las Vegas Clinical Research Unit, Las Vegas